Brian M. Culley, President and CEO at Lineage Cell Therapeutics, Inc. (LCTX), bought 40,000 shares at $0.60 ($24K) on 2024-11-21, disclosed to the SEC on 2024-11-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| LCTX | BUY | 2022-04-04 | $10K | — | Filing → |
| LCTX | BUY | 2022-03-28 | $7K | — | Filing → |
| LCTX | SELL | 2021-06-30 | $1.3M | — | Filing → |